True Diagnostics™

True Diagnostics™ is a leading biotechnology company committed to developing innovative point-of-care (POC) diagnostic tests and devices. Utilizing the proprietary TrueDX™ Platform, True Diagnostics™ delivers rapid and reliable diagnoses, facilitating timely treatment decisions in various settings, including point-of-care, point-of-incidence, and remote-of-care environments. The company's focus on reliable and low-cost lab methods ensures accessibility and accuracy.

The TrueDX™ Platform's portability and affordability make it ideal for adoption in emerging markets, providing accurate diagnoses within minutes. True Diagnostics™ addresses the significant $21 billion point-of-care market with its simple yet powerful platform. The company's tests boast an 18-month or longer shelf life and do not require refrigeration, ensuring ease of use and storage.

Located at 2782 Loker Ave West, Carlsbad, US, True Diagnostics™ has a flexible platform design which allows for the swift commercialization of biomarkers discovered for a wide range of conditions, including cancer, autism, Alzheimer’s, diabetes, drugs of abuse, infectious diseases, cardiac health, traumatic brain injury, and viral and bacterial infections. We invite the manager of True Diagnostics™ to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.